🔎 Trials Near Me

Utama › Lupus › Texas › Houston

Kajian klinikal Lupus di Houston, TX

13 kajian untuk Lupus sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Mengambil pesertaFasa 3
  • Sl0044 50696, Houston
  • Sl0044 50723, Houston
  • Sl0044 50738, Bellaire · 7 mi jauh
Umur 16 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06617325

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Mengambil pesertaFasa 2
  • Prolato Clinical Research Center, Houston
Umur 18 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05268289

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Mengambil pesertaFasa 2
  • The University of Texas Health Science Center at Houston, Houston
Umur 18 hingga 74 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07409181

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Mengambil pesertaFasa 3
  • Novel Research LLC, Bellaire · 7 mi jauh
Umur 12 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06133972

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Mengambil pesertaFasa 3
  • Research Site, Houston
Umur 5 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05835310

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Mengambil pesertaFasa 3
  • Research Site, Houston
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07430306

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Mengambil pesertaFasa 1
  • UT MD Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Mengambil pesertaFasa 1
  • Baylor College of Medicine, Houston
Umur 18 hingga 60 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06975787

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Mengambil pesertaFasa 3
  • Accurate Clinical Research, Humble · 17 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07355218

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Mengambil pesertaFasa 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Umur 18 hingga 65 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06121297

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Mengambil pesertaFasa 3
  • Novel Research, LLC., Houston
  • Northwest Houston Arthritis, Houston
  • Rheumatology Care Center, PLLC, Bellaire · 7 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07201129

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Mengambil pesertaKajian pemerhatian
  • M D Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Mengambil pesertaFasa 1/2
  • MD Anderson Cancer Center, Houston
  • The University of Texas Health Science Center at Houston, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT06434363

Kajian Lupus di bandar lain

Kajian lain di Houston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.